You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Chemistry
Synthetic Route Discovery
Chemical process development is laboratory-based and focuses on route scouting after identifying a target molecule. Chemists investigate the most efficient synthetic approach and produce large quantities of the molecule for further studies, including preclinical and clinical research.
- Generally, evaluate 3-5 potential synthetic strategies
- Focus on key transformations
- Ensure freedom to operate
Learn more about